The US FDA approved Eli Lilly's Zepbound as the first ever medication for obstructive sleep apnea for patients who also have ...

Anti-obesity medication use was associated with reduced alcohol consumption among patients in a telehealth medical weight ...

This proposed rule signals an important shift in the federal approach to obesity management, aligning with the medical ...

Elon Musk showed off a trimmer figure in a holiday social media post on Wednesday while revealing that he has been taking an ...

Starting in the new year, Independence Blue Cross, the region’s largest health insurer, will no longer cover anti-obesity drugs like Ozempic and Wegovy when they’re prescribed solely for weight loss.

Obesity has emerged as one of the most pressing public health challenges globally, affecting over 650 million adults, ...

Pennsylvania's Medicaid spending per enrollee on Wegovy, Zepbound, and other anti-obesity drugs was third-highest in the ...

The Food and Drug Administration on Friday approved Eli Lilly’s weight-loss drug Zepbound to treat sleep apnea, a common but ...

Emily Armistead warns that addressing the obesity crisis requires remaking a food system that is harming us and the planet.

The Biden administration has unveiled a major proposal to expand Medicare and Medicaid coverage for anti-obesity drugs, ...

Obesity continues to plague New Yorkers, affecting almost two out of every three adults in our state. That’s why I’m pushing ...

If coverage is structured properly, it could greatly help our country's chronic disease and obesity epidemics. But Donald Trump's Food and Drug Administration (FDA) will also need to ensure the drugs ...